SLC6A2 and childhood malignant neoplasm: Currently, for childhood cancers and more specifically norepinephrine transporter (NET) positive neuroblastoma tumors, [123/131I]meta-iodobenzylguanidine ([123/131I]mIBG) is the only available theranostic to date (14–16).